What is the share price of Samsrita Labs Ltd (SAMSRITA) today?
The share price of SAMSRITA as on 5th December 2025 is ₹21.57. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Samsrita Labs Ltd (SAMSRITA) share?
The past returns of Samsrita Labs Ltd (SAMSRITA) share are- Past 1 week: 1.60%
- Past 1 month: -5.49%
- Past 3 months: 14.55%
- Past 6 months: 7.85%
- Past 1 year: -3.49%
- Past 3 years: -25.88%
- Past 5 years: -55.20%
What are the peers or stocks similar to Samsrita Labs Ltd (SAMSRITA)?
The peers or stocks similar to Samsrita Labs Ltd (SAMSRITA) include:What is the market cap of Samsrita Labs Ltd (SAMSRITA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Samsrita Labs Ltd (SAMSRITA) is ₹49.07 Cr as of 5th December 2025.What is the 52 week high and low of Samsrita Labs Ltd (SAMSRITA) share?
The 52-week high of Samsrita Labs Ltd (SAMSRITA) is ₹26.04 and the 52-week low is ₹12.19.What is the PE and PB ratio of Samsrita Labs Ltd (SAMSRITA) stock?
The P/E (price-to-earnings) ratio of Samsrita Labs Ltd (SAMSRITA) is -169.21. The P/B (price-to-book) ratio is 4.10.Which sector does Samsrita Labs Ltd (SAMSRITA) belong to?
Samsrita Labs Ltd (SAMSRITA) belongs to the Health Care sector & Biotechnology sub-sector.How to buy Samsrita Labs Ltd (SAMSRITA) shares?
You can directly buy Samsrita Labs Ltd (SAMSRITA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Samsrita Labs Ltd
SAMSRITA Share Price
21.570.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SAMSRITA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
SAMSRITA Performance & Key Metrics
SAMSRITA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -10.53 | 4.10 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
SAMSRITA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SAMSRITA Company Profile
Samsrita Labs Ltd is a biopharma company engaged in manufacturing bulk drugs, stem cell research, and molecular diagnostics, focusing on innovative healthcare solutions.
BIOCON
PE Ratio
51.17
51.17
1Y Return
2.28%
2.28%
Buy Reco %
70.59
70.59
ANTHEM
PE Ratio
82.39
82.39
1Y Return
9.36%
9.36%
Buy Reco %
66.67
66.67
ONESOURCE
PE Ratio
-1,063.50
-1,063.50
1Y Return
2.47%
2.47%
Buy Reco %
100.00
100.00
SAILIFE
PE Ratio
107.20
107.20
1Y Return
13.45%
13.45%
Buy Reco %
100.00
100.00
ACUTAAS
PE Ratio
88.16
88.16
1Y Return
51.31%
51.31%
Buy Reco %
100.00
100.00
SAMSRITA Forecast
SAMSRITA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SAMSRITA
SAMSRITA
Income
Balance Sheet
Cash Flow
Annual Normal View
SAMSRITA Income Statement
SAMSRITA Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1.29 | 0.63 | 2.01 | 1.59 | 0.16 | 1.93 | 0.31 | 0.00 | 0.00 | 0.08 | ||||||||||
Raw Materials | 1.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 | 5.35 | ||||||||||
| Power & Fuel Cost | 0.01 | 0.02 | 0.37 | 0.31 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.22 | 0.71 | 1.48 | 1.40 | 0.33 | 0.11 | 0.13 | 0.13 | 0.13 | |||||||||||
| Selling & Administrative Expenses | 0.35 | 0.80 | 2.13 | 1.48 | 0.26 | 0.09 | 0.06 | 0.07 | 0.08 | |||||||||||
| Operating & Other expenses | 0.04 | 0.19 | 0.37 | 0.43 | 0.08 | 0.20 | 0.80 | 0.05 | 0.05 | |||||||||||
EBITDA | -0.57 | -1.09 | -2.34 | -2.03 | -0.76 | 1.51 | -0.70 | -0.25 | -0.26 | -5.27 | ||||||||||
| Depreciation/Amortization | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | -0.58 | -1.10 | -2.36 | -2.05 | -0.77 | 1.50 | -0.70 | -0.25 | -0.26 | -5.27 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBT | -0.58 | -1.10 | -2.37 | -2.06 | -0.77 | 1.50 | -0.70 | -0.25 | -0.26 | -5.27 | ||||||||||
| Taxes & Other Items | 0.72 | -0.06 | -0.03 | -0.07 | 0.00 | 0.01 | 0.00 | 0.01 | 0.03 | -0.61 | ||||||||||
| Net Income | -1.30 | -1.04 | -2.34 | -1.99 | -0.77 | 1.49 | -0.70 | -0.26 | -0.29 | -4.66 | ||||||||||
| EPS | -1.27 | -0.94 | -1.83 | -1.39 | -0.52 | 1.01 | -0.47 | -0.18 | -0.20 | -3.15 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SAMSRITA Company Updates
SAMSRITA Stock Peers
SAMSRITA Past Performance & Peer Comparison
SAMSRITA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareBiotechnology
Compare valuation on Screener
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Samsrita Labs Ltd | -169.21 | 4.10 | — |
| Biocon Ltd | 51.17 | 1.87 | 0.12% |
| Anthem Biosciences Ltd | 82.39 | 15.43 | — |
| Onesource Specialty Pharma Ltd | -1,063.50 | 3.25 | — |
SAMSRITA Stock Price Comparison
Compare SAMSRITA with any stock or ETFCompare SAMSRITA with any stock or ETF
SAMSRITA
SAMSRITA Holdings
SAMSRITA Shareholdings
SAMSRITA Promoter Holdings Trend
SAMSRITA Promoter Holdings Trend
SAMSRITA Institutional Holdings Trend
SAMSRITA Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 1.69%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SAMSRITA Shareholding Pattern
SAMSRITA Shareholding Pattern
SAMSRITA Shareholding History
SAMSRITA Shareholding History
Foreign Institutions
smallcases containing SAMSRITA stock
smallcases containing SAMSRITA stock
Looks like this stock is not in any smallcase yet.
SAMSRITA Events
SAMSRITA Events
SAMSRITA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SAMSRITA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SAMSRITA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SAMSRITA has not given any dividends in last 5 years
SAMSRITA Dividends
SAMSRITA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSAMSRITA Stock News & Opinions
SAMSRITA Stock News & Opinions
Articles & Videos
Earnings
Samsrita Labs reports standalone net loss of Rs 4.94 crore in the September 2025 quarter
Net Loss of Samsrita Labs reported to Rs 4.94 crore in the quarter ended September 2025 as against net loss of Rs 0.04 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 and during the previous quarter ended September 2024.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Samsrita Labs to announce Quarterly Result
Samsrita Labs will hold a meeting of the Board of Directors of the Company on 25 October 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Samsrita Labs to conduct board meeting
Samsrita Labs will hold a meeting of the Board of Directors of the Company on 8 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Samsrita Labs schedules AGM
Samsrita Labs announced that the 29th Annual General Meeting(AGM) of the company will be held on 25 August 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Samsrita Labs reports standalone net loss of Rs 0.28 crore in the June 2025 quarter
Net Loss of Samsrita Labs reported to Rs 0.28 crore in the quarter ended June 2025 as against net loss of Rs 0.09 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Samsrita Labs to announce Quarterly Result
Samsrita Labs will hold a meeting of the Board of Directors of the Company on 18 July 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Samsrita Labs to conduct EGM
Samsrita Labs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 May 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Samsrita Labs to convene board meeting
Samsrita Labs will hold a meeting of the Board of Directors of the Company on 30 April 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Samsrita Labs reports standalone net loss of Rs 0.09 crore in the March 2025 quarter
Net Loss of Samsrita Labs reported to Rs 0.09 crore in the quarter ended March 2025 as against net loss of Rs 0.07 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.26 crore in the year ended March 2025 as against net loss of Rs 0.25 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Samsrita Labs to convene board meeting
Samsrita Labs will hold a meeting of the Board of Directors of the Company on 26 April 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
In last 6 months, promoter holding in the company has decreased by 17.86%
Pledged promoter holdings is insignificant